Healthy ParticipantsAnxiety Disorders (With High Anxiety Symptoms)Depressive Disorders (With High Anhedonia Symptoms)Comorbid Depression and Anxiety Disorder (With High Anhedonia and High Anxiety Symptoms)
Investigational drug(s) / intervention(s)
tVNSSham
tVNS: The intervention consists of event-triggered tVNS in the form of short pulses (\~1-5s; frequency: 25Hz). A non-CE-certified and non-medical device (tVNS® R tVNS technologies, for research purposes) will be used. Stimulation intensity will be individually calibrated to ensure perceptible (mild pricking) but non-painful stimulation for each participant. The protocol is the same for all groups.
Sham: The sham condition similarly consists of event-triggered, closed-loop stimulation, but without vagus nerve activation (short pulses of 1-5s; frequency: 25Hz). A non-CE-certified and non-medical device (tVNS® R, for research purposes) will be used. The manufacturer is not involved in the study. Stimulation intensity will be individually calibrated to ensure perceptible (mild pricking) but non-painful stimulation for each participant. The protocol is the same for all groups.
Study summary
This study investigates if anhedonia and anxiety symptoms are associated with alterations in reinforcement learning, effort trade-offs for wins vs. punishments, and foraging behavior under threat. Moreover, it will investigate whether these processes can be influenced by a metabolic load and/or transcutaneous vagus nerve stimulation (tVNS). The project consists of (a) an online reinforcement learning study, used to characterize learning, reward sensitivity, and meta-cognition, and (b) a laboratory study in which participants first undergo fMRI while completing an effort-based decision-making task. Second, participants will complete two sessions in VR with randomized active or sham tVNS during a foraging task before and after a caloric load with concurrent physiological recordings.
Eligibility
Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* BMI between 18,5 and 30,0 kg/m2,
* between 18 and 40 years of age, and
* be able and willing to provide informed consent.
Exclusion Criteria:
* have a high risk of suicide,
* have a lifetime diagnosis of severe neurological disorder (incl. ADHD), schizophrenia, bipolar disorder, or severe substance abuse, posttraumatic stress disorder, obsessive-compulsive disorder, diabetes, epilepsy, or coronary heart disease
* have fulfilled criteria for an eating disorder or somatic symptom disorder within the last 12-months,
* take medication (except psychopharmacological medication for MDD or anxiety), patients have to be on stable psychopharmacological medication for at least two months before study participation (minimizing confounding effects)
* contraindications for MRI (metal implants or claustrophobia)
* for female individuals if they are pregnant or nursing at the time,
* impaired movement ability or hearing
* impaired, uncorrected vision (need contact lenses)
* contraindications for tVNS hearing aids or diseased skin on the right ear.
Primary outcome measure(s)
Stimulation-induced changes in the number of rewards collected under threat (VR foraging task) — During each stimulation session (tVNS and sham) throughout study completion (approximately 3 weeks) The number of rewards collected during a VR foraging task will be compared between stimulation conditions (tVNS vs. sham).
BOLD response during the effort-trade-off task (offer-phase) — Collected during fMRI session (single session throughout study completion ~35min per participant) The outcome describes task-evoked neural activation (BOLD response) during the offer phase of the effort trade-off task.
Neural activation is measured as a task-evoked BOLD response during offer presentation.
Reward learning — Online task performance assessed online before lab-visits (approximately 10 days) Reward learning is repeatedly measured during an online bandit task with fluctuating reward probabilities.
Reward learning behavior will be collected online in 10 runs spread over 5 to 10 days, each including 150 trials.
Metabolic state x stimulation-induced changes in the number of rewards collected under threat (VR task) — During each stimulation session (tVNS and sham) throughout study completion (approximately 3 weeks) The number of rewards collected during a VR foraging task will be compared between two different metabolic states (fasted vs. postprandial) and stimulation conditions (tVNS vs. sham).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.